JP-153, identified by its CAS number 1802937-26-3, is a synthetic chemical compound that has garnered attention in various fields, particularly in medicinal chemistry and pharmacology. It is characterized by its specific molecular structure, which contributes to its unique biological activity. JP-153 is often studied for its potential therapeutic applications, particularly in the context of neuropharmacology, where it may exhibit effects on neurotransmitter systems. The compound's solubility, stability, and reactivity are important factors that influence its behavior in biological systems and its potential for drug development. Additionally, JP-153 may possess specific pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), which are critical for understanding its efficacy and safety profile. As research continues, the full range of its characteristics, including its mechanism of action and potential side effects, will be elucidated, contributing to a better understanding of its role in therapeutic contexts.

JP-153

1802937-26-3: JP-153, identified by its CAS number 1802937-26-3, is a synthetic chemical compound that has garnered attention in various fields, particularly in medicinal chemistry and pharmacology. It is characterized by its specific molecular structure, which contributes to its unique biological activity. JP-153 is often studied for its potential therapeutic applications, particularly in the context of neuropharmacology, where it may exhibit effects on neurotransmitter systems. The compound's solubility, stability, and reactivity are important factors that influence its behavior in biological systems and its potential for drug development. Additionally, JP-153 may possess specific pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion (ADME), which are critical for understanding its efficacy and safety profile. As research continues, the full range of its characteristics, including its mechanism of action and potential side effects, will be elucidated, contributing to a better understanding of its role in therapeutic contexts.

<p>JP-153 is an inhibitor of Src-FAK-Paxillin signaling. It suppresses Src-dependent phosphorylation of paxillin (Y118) and subsequent activation of Akt (S473). JP-153 reduces VEGF-induced migration and proliferation of retinal endothelial cells and is applicable in the study of neovascular eye diseases.</p>

CAS 1802937-26-3

JP-153

JP-153

Ref: TM-T206442